Skip to main content
. 2019 Nov 8;10:771. doi: 10.3389/fendo.2019.00771

Table 4.

Clinical characteristics, hormonal levels, and oxidative stress parameters of the GPx P198L (Pro198Leu) genotypes in PCOS patients and controls.

Controls PCOS
PP PL+LL PP PL+LL
(n = 490) (n = 43+2) (n = 562) (n = 88+4)
Age (years) 28.12 ± 4.17 28.42 ± 3.97 25.07 ± 4.15 24.60 ± 4.58
BMI (kg/m2) 21.14 ± 2.92 20.88 ± 2.23 23.28 ± 4.28 22.94 ± 4.20
Waist circumference (cm) 73.82 ± 8.37 73.29 ± 6.90 79.97 ± 11.45 80.36 ± 11.32
Waist-to-hip ratio 0.81 ± 0.06 0.81 ± 0.06 0.85 ± 0.07 0.85 ± 0.07
F-G score 0.25 ± 0.74 0.29 ± 0.59 1.72 ± 2.04 1.87 ± 2.24
Acne grade score 0.14 ± 0.34 0.16 ± 0.37 0.69 ± 0.92 0.38 ± 0.77b
SBP (mmHg) 112.61 ± 11.51 116.50 ± 10.60a 114.66 ± 10.81 115.97 ± 10.09
DBP (mmHg) 73.77 ± 8.81 73.14 ± 6.70 75.69 ± 9.08 76.39 ± 8.08
AOV (ml) 7.65 ± 2.99 7.59 ± 1.71 9.96 ± 3.89 10.99 ± 5.03
Hormonal levels
TT (nmol/L) 1.51 ± 0.53 1.58 ± 0.51 2.35 ± 0.78 2.37 ± 0.71
SHBG (nmol/L) 55.14 ± 27.68 46.22 ± 15.33 35.27 ± 28.02 34.25 ± 18.11
FAI 3.27 ± 2.11 3.85 ± 2.22 9.89 ± 7.26 9.10 ± 5.70
LH/FSH 1.24 ± 1.15 1.44 ± 2.00 2.30 ± 1.30 2.27 ± 1.17
Oxidative stress parameters
TOS (nmol H2O2 Equiv./mL) 11.15 ± 5.18 12.19 ± 6.61 14.82 ± 10.72 15.59 ± 11.12
T-AOC (U/ml/min) 14.52 ± 2.69 14.28 ± 2.78 15.76 ± 3.09 15.99 ± 2.90
OSI 0.79 ± 0.39 0.91 ± 0.57 0.98 ± 0.78 1.02 ± 0.83
MDA (nmol/ml) 3.64 ± 1.06 3.88 ± 1.22 4.31 ± 1.23 4.57 ± 1.71

Values are presented as mean ± SD.

AOV, average ovarian volume; BMI, body mass index; DBP, diastolic blood pressure; FAI, free androgen index; F-G score, Ferriman–Gallwey score; FSH, follicle-stimulating hormone; LH, luteinizing hormone; MDA, malondialdehyde; OSI, oxidative stress index; SBP, systolic blood pressure; SHBG, sex hormone-binding globulin; T-AOC, total antioxidant capacity; TOS, total oxidant status; TT, total testosterone.

Comparisons of all parameters were corrected for differences in age and BMI between the 2 subgroups except the parameters of age and BMI.

a

P < 0.05, compared with the PP genotype subgroup in controls.

b

P < 0.01, compared with the PP genotype subgroup in PCOS patients.